参考文献/References:
[1] Planas R,Montoliu S, Balleste B, et al. Natural history of patients
hospitalized for management of cirrhotic ascites[J]. Clin Gastroenterol
Hepatol,2006,4(11):1385-1394.
[2] Krag A,Bendtsen F,Henriksen J H,et al. Low cardiac output predicts development
of hepatorenal syndrome and survival in patients with cirrhosis and ascites[J].
Gut,2010,59(1):105-110.
[3] 中华医学会肝病学分会. 肝硬化腹水及相关并发症的诊疗指南[J]. 临床肝胆病杂
志,2017,33(10):1847-1863.
[4] de Franchis R. Expanding consensus in portal hypertension:Report of the Baveno
VI Consensus Workshop: Stratifying risk and individualizing care for portal
hypertension[J]. J Hepatol,2015,63(3):743-752.
[5] Bureau C,Thabut D,Oberti F,et al. Transjugular Intrahepatic Portosystemic
Shunts With Covered Stents Increase Transplant-Free Survival of Patients With
Cirrhosis and Recurrent Ascites[J]. Gastroenterology,2017,152(1):157-163.
[6] Bucsics T,Hoffman S,Grunberger J,et al. ePTFE-TIPS vs repetitive LVP plus
albumin for the treatment of refractory ascites in patients with cirrhosis[J].
Liver Int,2018,38(6):1036-1044.
[7] Geeroms B,Laleman W,Laenen A,et al. Expanded polytetrafluoroethylene-covered
stent-grafts for transjugular intrahepatic portosystemic shunts in cirrhotic
patients:Long-term patency and clinical outcome results[J]. Eur Radiol,2017,27
(5):1795-1803.
[8] Ferral H,Gamboa P,Postoak D W,et al. Survival after elective transjugular
intrahepatic portosystemic shunt creation: prediction with model for end-stage
liver disease score[J]. Radiology,2004,231(1):231-236.
[9] Maleux G,Perez-Gutierrez N A,Evrard S,et al. Covered stents are better than
uncovered stents for transjugular intrahepatic portosystemic shunts in cirrhotic
patients with refractory ascites:a retrospective cohort study[J]. Acta
Gastroenterol Belg,2010,73(3):336-341.
[10] Miraglia R,Maruzzelli L,Tuzzolino F,et al. Transjugular Intrahepatic
Portosystemic Shunts in Patients with Cirrhosis with Refractory Ascites:
Comparison of Clinical Outcomes by Using 8- and 10-mm PTFE-covered Stents[J].
Radiology,2017,284(1):281-288.
[11] Wang Q,Lv Y,Chen H,et al. Use of 8-mm Covered TIPS:Is "Losses without Gains"
the End of the Story?[J]. Radiology,2017,284(2):604.
[12] Gines P,Uriz J,Calahorra B,et al. Transjugular intrahepatic portosystemic
shunting versus paracentesis plus albumin for refractory ascites in cirrhosis[J].
Gastroenterology,2002,123(6):1839-1847.
相似文献/References:
[1]陈玲玲 吴梅梅 林伟国 郑伟兵 朱 琪.瞬时弹性成像技术在肝纤维化及脂肪肝诊断中的作用[J].福建医药杂志,2020,42(02):29.
CHEN Lingling,WU Meimei,LIN Weiguo,et al.Role of Fibroscan in the diagnosis of liver fibrosis and hepatic steatosis[J].FUJIAN MEDICAL JOURNAL,2020,42(02):29.
[2]林雪燕,黄胡萍,林志辉.特利加压素治疗肝硬化食管胃静脉曲张出血期间血钠下降的影响因素分析[J].福建医药杂志,2022,44(03):26.